KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Aterian (ATER) EBT (2018 - 2025)

Aterian has reported EBT over the past 8 years, most recently at $10.4 million for Q4 2025.

  • Quarterly results put EBT at $10.4 million for Q4 2025, changed 0.5% from a year ago — trailing twelve months through Dec 2025 was -$554000.0 (down 4161.54% YoY), and the annual figure for FY2025 was -$554000.0, down 4161.54%.
  • EBT for Q4 2025 was $10.4 million at Aterian, up from -$2.3 million in the prior quarter.
  • Over the last five years, EBT for ATER hit a ceiling of $227.7 million in Q4 2021 and a floor of -$117.0 million in Q3 2022.
  • Median EBT over the past 5 years was -$5.6 million (2023), compared with a mean of -$13.5 million.
  • Peak annual rise in EBT hit 613.4% in 2021, while the deepest fall reached 13631.06% in 2021.
  • Aterian's EBT stood at $227.7 million in 2021, then plummeted by 108.76% to -$19.9 million in 2022, then soared by 75.5% to -$4.9 million in 2023, then soared by 314.64% to $10.5 million in 2024, then dropped by 0.5% to $10.4 million in 2025.
  • The last three reported values for EBT were $10.4 million (Q4 2025), -$2.3 million (Q3 2025), and -$4.8 million (Q2 2025) per Business Quant data.